Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.398
-0.004 (-1.09%)
Dec 3, 2024, 11:58 AM EST - Market open
Aethlon Medical Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | - | - | 0.57 | 0.29 | 0.66 | 0.65 | Upgrade
|
| Revenue Growth (YoY) | - | - | 95.21% | -55.37% | 1.37% | 183.15% | Upgrade
|
| Gross Profit | - | - | 0.57 | 0.29 | 0.66 | 0.65 | Upgrade
|
| Selling, General & Admin | 10.71 | 11.77 | 12.47 | 10.72 | 8.55 | 6.58 | Upgrade
|
| Operating Expenses | 10.71 | 11.77 | 12.47 | 10.72 | 8.55 | 6.58 | Upgrade
|
| Operating Income | -10.71 | -11.77 | -11.9 | -10.42 | -7.89 | -5.93 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.05 | Upgrade
|
| Interest & Investment Income | 0.3 | 0.43 | 0.01 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -10.41 | -11.35 | -11.89 | -10.42 | -7.89 | -5.98 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.14 | - | - | - | Upgrade
|
| Other Unusual Items | -0.86 | -0.86 | - | - | - | -0.4 | Upgrade
|
| Pretax Income | -11.27 | -12.21 | -12.03 | -10.42 | -7.89 | -6.38 | Upgrade
|
| Earnings From Continuing Operations | -11.27 | -12.21 | -12.03 | -10.42 | -7.89 | -6.38 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0 | 0 | 0.01 | Upgrade
|
| Net Income | -11.27 | -12.21 | -12.03 | -10.42 | -7.89 | -6.37 | Upgrade
|
| Net Income to Common | -11.27 | -12.21 | -12.03 | -10.42 | -7.89 | -6.37 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 3 | 2 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 3 | 2 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 179.52% | 22.35% | 39.17% | 22.05% | 254.07% | 182.61% | Upgrade
|
| EPS (Basic) | -1.70 | -4.86 | -5.86 | -7.06 | -6.52 | -18.67 | Upgrade
|
| EPS (Diluted) | -1.70 | -4.86 | -5.86 | -7.06 | -6.52 | -18.67 | Upgrade
|
| Free Cash Flow | -8.92 | -10.38 | -11.45 | -10.12 | -6.82 | -5.35 | Upgrade
|
| Free Cash Flow Per Share | -1.34 | -4.13 | -5.57 | -6.86 | -5.64 | -15.66 | Upgrade
|
| Gross Margin | - | - | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | -2072.05% | -3542.53% | -1197.31% | -912.04% | Upgrade
|
| Profit Margin | - | - | -2094.89% | -3540.90% | -1196.58% | -980.33% | Upgrade
|
| Free Cash Flow Margin | - | - | -1993.62% | -3439.01% | -1035.47% | -822.73% | Upgrade
|
| EBITDA | -10.36 | -11.42 | -11.66 | -10.3 | -7.85 | -5.9 | Upgrade
|
| D&A For EBITDA | 0.35 | 0.36 | 0.24 | 0.12 | 0.04 | 0.03 | Upgrade
|
| EBIT | -10.71 | -11.77 | -11.9 | -10.42 | -7.89 | -5.93 | Upgrade
|
| Revenue as Reported | - | - | 0.57 | 0.29 | 0.66 | 0.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.